Biontech wants to investigate reports from the USA about irregularities in a study on the corona vaccine produced together with its partner Pfizer.
Mainz – Biontech wants to investigate reports from the USA about irregularities in a study on the corona vaccine produced together with partner Pfizer. “Careful implementation and data collection in clinical studies has the highest priority for Biontech,” said a spokeswoman for the Mainz company of the German press agency on Thursday. “We take statements such as those made in the article seriously and check them as soon as we become aware of them.” The specialist magazine “British Medical Journal” (“The BMJ”) had reported irregularities and errors in the study.
The background is information from a whistleblower (whistleblower) to “The BMJ”: According to this, the woman had worked in the USA in the fall of 2020 for a subcontractor that had carried out a small part of the study on the corona vaccine, which is now used worldwide, on behalf of Pfizer. She accused her former employer of generating incorrect vaccination data because, among other things, laboratory samples were incorrectly labeled, the vaccine was incorrectly stored and reports about side effects were only followed up slowly. German experts said they did not see the effectiveness of the drug being called into question by the allegations.
Oliver Cornely, scientific director of the Center for Clinical Studies in Cologne, said: “The errors described in” The BMJ “article do not limit the validity of the vaccine registration study.” The subcontractor’s investigation centers also looked after only 2.3 percent of the 44,000 participants in the study. (dpa)
#irregularities #Biontech #examine #study #corona #vaccine